The impact of smoking on outcomes among patients undergoing hematopoietic SCT for the treatment of acute leukemia
A paucity of research exists examining the potential impact of tobacco use on cancer treatment outcomes, especially among patients treated with hematopoietic SCT (HSCT). A retrospective cohort study design was used to examine the impact of smoking on duration of hospitalization and overall survival...
Gespeichert in:
Veröffentlicht in: | Bone marrow transplantation (Basingstoke) 2011-02, Vol.46 (2), p.285-290 |
---|---|
Hauptverfasser: | , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | A paucity of research exists examining the potential impact of tobacco use on cancer treatment outcomes, especially among patients treated with hematopoietic SCT (HSCT). A retrospective cohort study design was used to examine the impact of smoking on duration of hospitalization and overall survival among 148 consecutive patients undergoing HSCT for treatment of acute leukemia from 1999 to 2005. Of the 148 patients, 15% reported current smoking, 30% former smoking, and 55% never used tobacco. Patients were followed for a median 3.5 years (interquartile range=2.1–5.5). Compared to no history of smoking, current smoking was associated with worse pre-HSCT pulmonary function tests (
P |
---|---|
ISSN: | 0268-3369 1476-5365 |
DOI: | 10.1038/bmt.2010.113 |